Table 2.
Index Benzodiazepine Prescribed to Incident and Continuing Benzodiazepine Users
| N (%) | ||
|---|---|---|
| Index BZD prescriptiona |
Incident Cohort N=379,273 |
Continuing Cohort N=509,634 |
| Alprazolam | 133,530 (35.2) | 186,570 (36.6) |
| Lorazepam | 123,142 (32.5) | 146,991 (28.8) |
| Clonazepam | 33,376 (8.8) | 85,962 (16.9) |
| Diazepam | 61,668 (16.3) | 48,015 (9.4) |
| Temazepam | 23,172 (6.1) | 35,948 (7.1) |
| Clorazepate | 1,992 (0.5) | 4,480 (0.9) |
| Chlordiazepoxide | 1,688 (0.4) | 2,205 (0.4) |
| Triazolam | 1,273 (0.3) | 1,461 (0.3) |
| Oxazepam | 340 (0.1) | 1,003 (0.2) |
| Flurazepam | 200 (0.1) | 324 (0.1) |
BZD Benzodiazepine
aColumn percentages may sum to >100% due to some patients being prescribed >1 index BZD prescriptions on the same day. Only the top 10 BZDs are shown: estazolam, midazolam, and clobazam each accounted for ≤0.1% within each cohort